Nivolumab-induced hypothyroidism followed by isolated ACTH deficiency

Cancer immunotherapy has been used in several malignancies with clinical benefit. Despite the clinical success, immune-related adverse events are frequent and endocrinopathies can be particularly severe. We report a 55-year-old male patient with stage IV pulmonary carcinoma treated with nivolumab wh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMJ Case Rep
Autores principales: Martins Machado, Catarina, Almeida Santos, Lúcia, Barroso, Ana, Oliveira, Maria João
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2019
Materias:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6720681/
https://ncbi.nlm.nih.gov/pubmed/31466960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-231236
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares